Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05581953 · ClinicalTrials.gov registry record · NA
Protein-Distinct Macronutrient-Equivalent Diet 2
A NA study of Healthy Aging, sponsored by South Dakota State University.
- Active
- Registry status
- NA
- Development phase
- 59
- Enrollment target
- 1
- Study location
NCT05581953: Active NA study of Healthy Aging, sponsored by South Dakota State University.
NCT05581953 is a NA study of Healthy Aging that is active but no longer recruiting, run by South Dakota State University. The registered enrollment target is 59 participants, below the 120-participant average among 40 other Healthy Aging trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05581953, a NA study of Healthy Aging, is active but no longer recruiting, sponsored by South Dakota State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
The central hypothesis is that the addition of minimally processed lean pork to a healthy plant-forward low ultra-processed diet will enhance nutrient adequacy, promote muscular fitness, and maintain metabolic functions for improved healthspan. A well-designed, randomized, controlled, crossover, feeding study with clinical and molecular mechanistic endpoints is proposed to provide the most definitive level of evidence logistically possible in humans and to establish the role of minimally processed lean pork in healthspan promotion. Utilizing an all-food-provided (dine-in and take-out) design over 18 weeks (rolling recruitment, 8+8, 2w washout), a comprehensive assessment of metabolomics, system biology, physical, and physiological markers that indicate the risk of age-related comorbidities-critical micronutrient deficiency, frailty, metabolic dysfunctions, and cognitive decline, is proposed in upper Midwesterners 65 years and older. A minimally processed plant-forward diet with or without added pork will be compared for over 250 outcome measures using mixed-effects modeling adjusting for covariates in R. n=15/diet/arm i.e., a total starting sample size of n=30 is proposed for 90% power.
Primary Outcome
Using Microplate assay
Conditions Studied
Interventions
- OTHER Omnivorous
- OTHER No meat
Study Locations (1)
South Dakota
- South Dakota State University, Wagner Hall 416 - Brookings
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2022-11-15 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT05581953 still lists
NCT05581953 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 120-participant average among 40 other Healthy Aging trials with a reported enrollment target (51% lower).
The record links to 1 condition, with Healthy Aging appearing as the primary indexed condition, and to 2 interventions - of which Omnivorous is the first listed.
NCT05581953 reports a single indexed study location in South Dakota.
Frequently Asked Questions
What is clinical trial NCT05581953 about?
NCT05581953 is a clinical study titled "Protein-Distinct Macronutrient-Equivalent Diet 2". The central hypothesis is that the addition of minimally processed lean pork to a healthy plant-forward low ultra-processed diet will enhance nutrient adequacy, promote muscular fitness, and maintain metabolic functions for improved healthspan. A well-designed, randomized, controlled, crossover, fee...
What is the current status of trial NCT05581953?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 59 participants. The study started on 2022-11-15. Estimated completion is 2025-12-31.
What conditions does trial NCT05581953 study?
This clinical trial studies the following conditions: Healthy Aging.
What interventions are being tested in trial NCT05581953?
The interventions under investigation include: Omnivorous (OTHER), No meat (OTHER).
Who is sponsoring clinical trial NCT05581953?
This trial is sponsored by South Dakota State University, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05581953 being conducted?
This trial has 1 study location across South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05581953's enrollment target sits among peer trials
59 29th of 40 higher than 12 of 40 other Healthy Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Executive Control in Cognitively Healthy Older Adults: the MUltitasking STrategy (MUST) Study
RECRUITING · NA
-
The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots
RECRUITING · NA
-
Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+
RECRUITING · NA
-
Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging
RECRUITING · NA
-
iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults
RECRUITING · NA
-
Reactive Balance Training for Fall Prevention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI